DIALYSIS · CCN 212542

DaVita Mercy Dialysis

Baltimore, MD 21202

DialysisProfitDaVita
$6.3M
TOTAL REVENUE
16.1%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.3M
Total costs
$5.3M
Operating income (rev − costs)
$1.0M
Operating margin
16.1%
Total charges
$6.5M
Total treatments
17,207
Dialysis stations
30

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.5499—
Fistula Rate
DFC_FISTULA_RATE
49.1153—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.651—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
2——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
142.2115—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.19——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
18153—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.5452—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
13.5129—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.399—
Standardized ED Visits Ratio
DFC_SEDR
1.3868—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
18.755—